https://pubmed.ncbi.nlm.nih.gov/41748563/
Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer...
The cavity-creating p53 cancer mutation Y220C, which accounts for an estimated 125,000 new cancer cases per year, serves as an excellent paradigm for the...